New Podcast Episode: The Intersection of Motherhood and Chronic Illness feat. aHUS Patient Advocate Taylor Coffman
source: shutterstock.com

New Podcast Episode: The Intersection of Motherhood and Chronic Illness feat. aHUS Patient Advocate Taylor Coffman

We are excited to announce that Patient Worthy's award-winning podcast "Wait, How Do You Spell That? A Rare Disease Podcast" is back with a new episode. This week, Colby is…

Continue Reading New Podcast Episode: The Intersection of Motherhood and Chronic Illness feat. aHUS Patient Advocate Taylor Coffman

This Woman is the First Ever Patient to Have Both aHUS and Cobalamin C Deficiency

When the 19-year-old French woman first visited the hospital, she was extremely lethargic. She displayed neurological symptoms. Upon kidney failure, the patient was admitted into the ICU. But soon, doctors…

Continue Reading This Woman is the First Ever Patient to Have Both aHUS and Cobalamin C Deficiency
Atypical Hemolytic Uremic Syndrome & Pregnancy: Early Diagnosis Means Better Outcomes
source: pixabay.com

Atypical Hemolytic Uremic Syndrome & Pregnancy: Early Diagnosis Means Better Outcomes

Atypical hemolytic uremic syndrome (aHUS) is a rare condition which can be sparked by pregnancy, although it can also occur without it. Essentially, if you are genetically predisposed to the condition,…

Continue Reading Atypical Hemolytic Uremic Syndrome & Pregnancy: Early Diagnosis Means Better Outcomes

Alexion’s Ultomiris™ Met the Primary Objective in a Phase 3 Trial of Atypical Hemolytic Uremic Syndrome Patients

Alexion Pharmaceuticals, Inc., a company that is advancing a rare disease pipeline in complement biology, recently issued a series of press releases announcing positive results of a Phase 3 study…

Continue Reading Alexion’s Ultomiris™ Met the Primary Objective in a Phase 3 Trial of Atypical Hemolytic Uremic Syndrome Patients
How Much Would You Pay to Stay Alive? Read This Woman’s aHUS Story
https://pixabay.com/en/money-card-business-credit-card-256319/

How Much Would You Pay to Stay Alive? Read This Woman’s aHUS Story

According to CBC, Marie-Eve Chainey was on dialysis six out of seven days a week. For 15 years, this was her life. It was a necessary feat to control her…

Continue Reading How Much Would You Pay to Stay Alive? Read This Woman’s aHUS Story
Atypical Hemolytic Uremic Syndrome Patients: There’s a new Medicine Coming to the Market!
https://pixabay.com/en/medicine-pills-bottles-medical-296966/

Atypical Hemolytic Uremic Syndrome Patients: There’s a new Medicine Coming to the Market!

ChemoCentrx has been working to develop a drug to combat auto-antibody-associated vasculitis (AAV), C3 glomerulopathy (C3G), and atypical hemolytic uremic syndrome (aHUS). Its name- Avacopan. ChemoCentryx has always had a…

Continue Reading Atypical Hemolytic Uremic Syndrome Patients: There’s a new Medicine Coming to the Market!